AIM1L Inhibitors
AIM1L inhibitors encompass a diverse group of chemical compounds that indirectly modulate the function of the AIM1L protein through various cellular pathways. These inhibitors primarily target key enzymes and signaling molecules that are upstream or downstream of the pathways AIM1L is involved in, thereby influencing its activity. The inhibition mechanisms include disrupting kinase activities, modulating signal transduction, and altering cell growth and survival pathways. The inhibitors are predominantly kinase inhibitors, targeting a range of kinases like PI3K, MAPK, mTOR, JNK, Src family kinases, and RAF. By inhibiting these kinases, they interfere with crucial signaling cascades that play a role in cell proliferation, apoptosis, inflammation, and other cellular responses. For example, PI3K inhibitors like Wortmannin and LY 294002 can disrupt the PI3K/AKT/mTOR pathway, a critical pathway in cell growth and survival, potentially affecting proteins like AIM1L that may be involved in similar pathways. Similarly, inhibitors like U0126 and PD 98059, targeting the MEK enzyme, can modulate the MAPK/ERK pathway, which is crucial for cell division and differentiation.
In addition to kinase inhibitors, this class includes compounds that affect other signaling molecules and pathways. For instance, Rapamycin, an mTOR inhibitor, not only disrupts cell growth pathways but also has implications for autophagy and metabolism, which could indirectly influence AIM1L's role in these processes. The diversity of these inhibitors in their targets and modes of action underlines the complexity of cellular signaling and the intricate ways in which AIM1L's function can be modulated. This chemical class represents a critical tool in exploring the function of AIM1L and its role in cellular processes, providing insights into the broader implications of protein modulation in cellular biology.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a non-selective protein kinase inhibitor that can diminish the activity of multiple kinases which phosphorylate AIM1L, potentially reducing its activity by altering its phosphorylation status. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 is a phosphatidylinositol 3-kinase (PI3K) inhibitor that may lead to the inhibition of the AKT signaling pathway. Since AKT can modulate various proteins including AIM1L, the inhibition of PI3K/AKT signaling can result in decreased function or stabilization of AIM1L. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits the mTOR pathway, which is involved in cell growth and survival. Inhibiting mTOR could lead to reduced protein synthesis and indirectly diminish the functional stability of AIM1L in the cells. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 is a specific inhibitor of MEK, which acts upstream of ERK in the MAPK signaling pathway. By inhibiting MEK, PD 98059 can decrease ERK-mediated signaling processes that may affect the phosphorylation and activity of AIM1L. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580 is a specific inhibitor of p38 MAPK. Inhibition of p38 MAPK can lead to a decrease in the phosphorylation of downstream targets, which can indirectly lower the activity of AIM1L if such pathways are involved in AIM1L regulation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, which is part of the MAPK signaling pathways. Inhibition of JNK can alter transcription factor activity and gene expression that may be crucial for AIM1L function, thereby reducing its activity indirectly. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent inhibitor of PI3K and can diminish AKT activation. Reduced AKT signaling can decrease the phosphorylation of substrates that might be involved in maintaining AIM1L's function or stability, resulting in its reduced activity. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
GF109203X is a specific inhibitor of protein kinase C (PKC). PKC is involved in various signaling pathways that can regulate the function of numerous proteins. Inhibition of PKC may therefore diminish the functional activity of AIM1L if it is regulated by PKC-mediated pathways. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is a proteasome inhibitor that can lead to the accumulation of misfolded proteins, inducing stress responses that can negatively impact the stability of proteins like AIM1L. Hence, proteasome inhibition can indirectly reduce AIM1L functional activity. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
ZM-447439 is an Aurora kinase inhibitor. By inhibiting Aurora kinases, it can affect cell cycle progression and mitotic processes. If AIM1L is involved in cell cycle regulation or mitosis, its activity could be diminished as a result of Aurora kinase inhibition. | ||||||